Compared to psoriasis vulgaris, and pediatric or biologic-naïve adult cases of Blaschkoid psoriasis treated with IL-17 inhibitors, treatment response in this case was attenuated, with partial clearance after 6 months.2 This evidence concerns the gene IL17A and psoriasis vulgaris.